BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhen Y, Luo C, Zhang H. Early detection of ulcerative colitis-associated colorectal cancer. Gastroenterol Rep (Oxf) 2018;6:83-92. [PMID: 29780595 DOI: 10.1093/gastro/goy010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu XR, Zheng XB, Huang Y, Cao Q, Zhang HJ, Miao YL, Zou KF, Chen M, Zhang FM, Mei Q, Gonzalo D, Allende D, Hu PJ, Shen B, Liu XL, Lan P. Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study. Gastroenterol Rep (Oxf) 2019;7:67-73. [PMID: 30792868 DOI: 10.1093/gastro/goy039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Reference Citation Analysis]
3 Direito R, Rocha J, Lima A, Gonçalves MM, Duarte MP, Mateus V, Sousa C, Fernandes A, Pinto R, Boavida Ferreira R, Sepodes B, Figueira ME. Reduction of Inflammation and Colon Injury by a Spearmint Phenolic Extract in Experimental Bowel Disease in Mice. Medicines (Basel) 2019;6:E65. [PMID: 31174376 DOI: 10.3390/medicines6020065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci 2021;22:5421. [PMID: 34063828 DOI: 10.3390/ijms22115421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Awasthi A, Barbour J, Beggs A, Bhandari P, Blakeway D, Brookes M, Brown J, Brown M, Caldwell G, Clokie S, Colleypriest B, Conlin A, de Silva S, de Caestecker J, Deeks J, Dhar A, Dilworth M, Fogden E, Foley S, Ghosh D, Grellier L, Hart A, Hoque SS, Iacucci M, Iqbal T, James J, Jarvis M, Jayaprakash A, Keshav S, Magill L, Matthews G, Mawdsley J, Mclaughlin S, Mehta S, Monahan K, Morton D, Murugesan S, Parkes M, Pestinger V, Probert C, Ramadas A, Rettino A, Sebastian S, Sharma N, Griffiths M, Stockton J, Subramanian V, Suggett N, Taniere P, Teare J, Verma AM, Wallis Y. Enhanced neoplasia detection in chronic ulcerative colitis: the ENDCaP-C diagnostic accuracy study. Efficacy Mech Eval 2021;8:1-88. [DOI: 10.3310/eme08010] [Reference Citation Analysis]
6 Hallajzadeh J, Maleki Dana P, Mobini M, Asemi Z, Mansournia MA, Sharifi M, Yousefi B. Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer. Med Oncol 2020;37:49. [PMID: 32303850 DOI: 10.1007/s12032-020-01367-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Chen K, Zeng Z, Ma C, Dang Y, Zhang H. Commentary on: Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers. Biosci Rep 2021;41:BSR20211096. [PMID: 34850851 DOI: 10.1042/BSR20211096] [Reference Citation Analysis]
8 Vaghari-Tabari M, Targhazeh N, Moein S, Qujeq D, Alemi F, Majidina M, Younesi S, Asemi Z, Yousefi B. From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs? Cancer Cell Int 2022;22:146. [PMID: 35410210 DOI: 10.1186/s12935-022-02557-3] [Reference Citation Analysis]
9 Wang J, Pei B, Yan J, Xu X, Fang AN, Ocansey DKW, Zhang X, Qian H, Xu W, Mao F. hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis. Mol Pharm 2022. [PMID: 35084199 DOI: 10.1021/acs.molpharmaceut.1c00450] [Reference Citation Analysis]
10 Blachier F, Beaumont M, Kim E. Cysteine-derived hydrogen sulfide and gut health: A matter of endogenous or bacterial origin. Curr Opin Clin Nutr Metab Care. 2019;22:68-75. [PMID: 30461448 DOI: 10.1097/mco.0000000000000526] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
11 El-Daly SM, Morsy SM, Medhat D, El-Bana MA, Latif YA, Omara EA, Awadallah JR, Gamal-Eldeen AM. The diagnostic efficacy of circulating miRNAs in monitoring the early development of colitis-induced colorectal cancer. J Cell Biochem 2019;120:16668-80. [PMID: 31095784 DOI: 10.1002/jcb.28925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Reznicek E, Arfeen M, Shen B, Ghouri YA. Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Diseases 2021;9:86. [PMID: 34842672 DOI: 10.3390/diseases9040086] [Reference Citation Analysis]
13 Jiang X, Jiang Z, Jiang M, Sun Y. Berberine as a Potential Agent for the Treatment of Colorectal Cancer. Front Med 2022;9:886996. [DOI: 10.3389/fmed.2022.886996] [Reference Citation Analysis]
14 Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
15 Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, Inflammation and Colorectal Cancer. Cells 2020;9:E618. [PMID: 32143413 DOI: 10.3390/cells9030618] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
16 Wan J, Zhang Q, Liang SH, Zhong J, Li JN, Ran ZH, Zhi FC, Wang XD, Zhang XL, Wen ZH, Sheng JQ, Shi HX, Mei Q, Wu KC. Chromoendoscopy with targeted biopsies is superior to white-light endoscopy for the long-term follow-up detection of dysplasia in ulcerative colitis patients: a multicenter randomized-controlled trial. Gastroenterol Rep (Oxf) 2021;9:14-21. [PMID: 33747522 DOI: 10.1093/gastro/goaa028] [Reference Citation Analysis]
17 Porter RJ, Arends MJ, Churchhouse AMD, Din S. Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. J Crohns Colitis 2021:jjab102. [PMID: 34111282 DOI: 10.1093/ecco-jcc/jjab102] [Reference Citation Analysis]
18 Mola S, Pandolfo C, Sica A, Porta C. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. Int J Mol Sci 2020;21:E6866. [PMID: 32962159 DOI: 10.3390/ijms21186866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Boros É, Nagy I. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019;8:E1461. [PMID: 31752264 DOI: 10.3390/cells8111461] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Braithwaite E, Carbonell J, Kane JS, Gracie D, Selinger CP. Patients' perception of colonoscopy and acceptance of colonoscopy based IBD related colorectal cancer surveillance. Expert Rev Gastroenterol Hepatol 2021;15:211-6. [PMID: 32981385 DOI: 10.1080/17474124.2021.1829971] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Zhao T, Han D, Meng H. Rab23 contributes to the progression of colorectal cancer via protein kinase B and extracellular signal-regulated kinase signaling pathways. Oncol Lett 2019;18:1793-9. [PMID: 31423247 DOI: 10.3892/ol.2019.10491] [Reference Citation Analysis]